— Know what they know.
Not Investment Advice

CRVO NASDAQ

CervoMed Inc.
1W: -3.1% 1M: -16.9% 3M: -10.5% YTD: -71.5% 1Y: -68.6% 3Y: -80.2% 5Y: -93.7%
$2.22
-0.02 (-0.89%)
 
Weekly Expected Move ±15.1%
$2 $2 $2 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $33.6M mcap · 10M float · 58.62% daily turnover · Short 51% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -8.18.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Cash Flow Trends

Operating Cash Flow
-$23M -41.9% ▼
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
-$23M -41.9% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$764K -163.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$24M-$6M-$2M-$16M-$27M
Depreciation & Amort.$93K$0$0$0$0
Stock-Based Comp.$897K$0$408K$1M$1M
Change in Working Capital$356K$380K-$261K-$441K$3M
Other Non-Cash Items$9M$3M-$5M-$1M-$854K
Operating Cash Flow-$15M-$3M-$7M-$17M-$23M
— Investing Activities —
Capital Expenditures$0$0$0$0$0
Acquisitions (Net)$4K$0$0$0$0
Investment Purchases$0$0$0-$48M-$25M
Investment Sales$0$0$0$19M$44M
Other Investing$0$0$0$0$0
Investing Cash Flow$4K$0$0-$29M$18M
— Financing Activities —
Net Debt Issuance$6M$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$4M$0$10M$0$0
Financing Cash Flow$33M$0$11M$46M$5M
Net Change in Cash$19M-$33M$4M$1M-$764K
Cash End of Period$37M$4M$8M$9M$8M
Free Cash Flow-$15M-$3M-$7M-$17M-$23M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms